G. Alonso et al., IMMUNOLOCALIZATION OF BCL-X(L S) IN THE CENTRAL-NERVOUS-SYSTEM OF NEONATAL AND ADULT-RATS/, Cell and tissue research, 288(1), 1997, pp. 59-68
A polyclonal antibody raised against a peptide corresponding to the (2
-19) amino-terminal sequence of the Bcl-x(L/S) protein was used to loc
alize Bcl-x immunostaining in the central nervous system of rats at va
rious postnatal ages. Whereas Bcl-x immunostaining was present in virt
ually all neurons of young animals (4 days postnatal), this staining b
ecame progressively restricted during the course of postnatal developm
ent. In adults, Bcl-x immunostaining was particularly strong in certai
n neurons present in a few hypothalamic nuclei, such as the supraoptic
or the arcuate nuclei. Moderate staining was observed in some discret
e brain regions, such as the olfactory bulb, the hippocampus, some cat
echolaminergic nuclei of the brainstem, and the cerebellum. Strong Bcl
-x immunostaining was also exhibited in axon-like fibers located in th
e pyriform cortex, the median eminence, the dorsal medulla oblongata,
and spinal cord. Bcl-x immunostaining was also present in astrocytes s
cattered throughout the white matter in the brain and the spinal cord,
but was absent from those located in gray matter. Staining was partic
ularly strongly expressed in reactive astrocytes densely packed along
the borders of a central lesion or surrounding them, and in a large nu
mber of reactive astrocytes detected at a distance from the lesion. Ou
r data suggest that, in addition to the possible stimulating effects o
n cell survival generally ascribed to Bcl-x, its maintained expression
throughout adulthood or its re-expression following injury characteri
zes those neuronal or non-neuronal cells of the adult central nervous
system that synthesize a range of molecules enabling them to adapt rap
idly and successfully to a changing environment.